Ventana Shareholders Tender 70.5 Percent of Shares to Roche | GenomeWeb
NEW YORK (GenomeWeb News) – Shareholders of Ventana Medical Systems have tendered 25.5 million shares, or 70.5 percent of Ventana’s outstanding stock, as of the close of the tender offer last night.
 
In January, after several months of pursuing Ventana, Roche finally reached an agreement to acquire the tissue-based diagnostics products firm for approximately $3.4 billion, or $89.50 per share. That was up from its previously rejected bid of $75 per share.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.